Compound Detail
CHEMBL1086
DIBUCAINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1086 |
| Name | DIBUCAINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PUFQVTATUTYEAL-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
17
Activities
3
Assay Types
0
PK Parameters
20
Publications
4
Known Names
3
Indications
Molecular Properties
343.5
MW (Da)
3.49
ALogP
4
HBA
1
HBD
54.5
PSA (Ų)
0.67
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Achiral |
Indications
Hemorrhoids Pruritus Sunburn
ATC Classification
C05AD04
cinchocaine
Level 1: CARDIOVASCULAR SYSTEM
Level 2: VASOPROTECTIVES
D04AB02
cinchocaine
Level 1: DERMATOLOGICALS
Level 2: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
N01BB06
cinchocaine
Level 1: NERVOUS SYSTEM
Level 2: ANESTHETICS
S01HA06
cinchocaine
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
S02DA04
cinchocaine
Level 1: SENSORY ORGANS
Level 2: OTOLOGICALS
Activity Summary
EC50 10 meas. best 5.77
IC50 6 meas. best 6.21
Ki 1 meas. best 6.26
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 6.26 | 6.26 | 550.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.21 | 5.97 | 610.0 | 3 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2096682 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| enterovirus D68 CHEMBL613204 | EC50 | 5.77 | 5.5967 | 1700.0 | 9 |
| Enterovirus A71 CHEMBL612436 | EC50 | 5.64 | 5.64 | 2275.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.38 | 4.38 | 41650.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30912944 | 10.1021/acs.jmedchem.9b00115 | Unchecked | 14 |
| 30912944 | 10.1021/acs.jmedchem.9b00115 | enterovirus D68 | 9 |
| 6167716 | 10.1021/jm00135a006 | ADMET | 8 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 23403082 | 10.1016/j.bmcl.2013.01.025 | Unchecked | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 2579237 | 10.1021/jm00381a019 | Sodium channel alpha subunits; brain (Types I, II, III) | 2 |
| - | 10.6019/CHEMBL4651402 | Vero C1008 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 22819594 | 10.1016/j.ejmech.2012.06.049 | NON-PROTEIN TARGET | 2 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 19346132 | 10.1016/j.bmc.2008.10.031 | Unchecked | 2 |
| 18189348 | 10.1021/jm7014809 | No relevant target | 2 |
| 18027916 | 10.1021/jm070524a | No relevant target | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-dependent L-type calcium channel subunit alpha-1C | 2 |
Data from ChEMBL 36 via Core Engine